col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


60 Results       Page 1

 [1] 
Medical Informational Agency Publishers: Clinical Medicine (Russian Journal)
  original article Date Title Authors   All Authors
1 [GO] 2026―Mar―16 SARS-CoV-2 induced myocarditis as a cause of acute decompensation in a patient with familial cardiomyopathy and a pathogenic variant in the titin gene A. L. Bezlyudskiy, K. M. Makarevich, K. A. Golosov, P. A. Kazaryan, A. P. Galkina, A. A. Litvinova, et al. (+2)
2 [GO] 2026―Mar―16 Brugada syndrome and COVID-19 N. A. Nikolaev, E. V. Osipenko, D. A. Anishchenko, T. I. Gaygiev
3 [GO] 2026―Mar―04 Features of the course of the new coronavirus infection in patients with bronchial asthma and allergic reactions A. S. Tambovskaya, V. A. Klyukina, S. G. Nekhaev
4 [GO] 2026―Feb―16 Features of diagnosis and treatment in patients with ST-segment elevation myocardial infarction and SARS-CoV-2 infection V. E. Ispavskii, N. V. Izmozherova, A. A. Popov, A. I. Cvetkov, S. V. Kozlov, V. S. Ermakov, V. N. Kravchuk
5 [GO] 2026―Feb―03 The features of the heart chamber remodeling process in patients with ST-segment elevation myocardial infarction and SARS-CoV-2 infection V. E. Ispavsky, N. V. Izmozherova, A. A. Popov, A. I. Cvetkov, I. F. Grishina, V. S. Ermakov, V. N. Kravchuk
6 [GO] 2025―Nov―26 Clinical and laboratory markers of lung damage in SARS-CoV-2 infection (omicron variant) in patients with end-stage chronic kidney disease P. I. Miklush, K. V. Zhdanov, A. N. Belskykh, K. V. Kozlov, A. K. Shvedov, M. V. Zaharov, et al. (+7)
7 [GO] 2025―Sep―22 Assessment of the prognostic ability of the platelet-to-lymphocyte ratio in patients with myocardial revascularization after coronavirus infection G. B. Batenova, E. I. Dedov, A. Yu. Orekhov, D. G. Ygieva, M. R. Pivina, L. M. Pivina
8 [GO] 2025―Aug―12 Pericardial effusion in coronavirus infection Z. N. Sukmarova, M. A. Saidova, M. K. Rybakova
9 [GO] 2025―Aug―12 Diagnosis and treatment of spontaneous hemorrhages in soft tissues in patients with COVID-19 K. V. Medvedev, D. A. Gusev, M. A. Protchenkov, V. A. Zinserling, I. A. Solovyov, A. V. Glebova, et al. (+2)
10 [GO] 2025―Aug―12 Clinical and laboratory features of acute myocardial infarction with elevation of the ST segment of the electrocardiogram, which developed against the background of COVID-19 V. E. Ispavsky, N. V. Izmozherova, A. A. Popov, A. I. Tsvetkov, I. P. Antropova, V. S. Ermakov, V. N. Kravchuk
11 [GO] 2025―Jun―09 Assessment of quality of life in patients after endovascular revascularization in combination with catheter-directed selective thrombolysis for acute limb ischemia developed in the acute stage of the new coronavirus infection COVID-19 A. V. Nikolsky, V. N. Kravchuk, N. A. Trofimov, A. S. Mukhin, A. D. Rybinsky, D. V. Volkov, et al. (+3)
12 [GO] 2025―May―09 Epidemiological study of the impact of COVID-19 on the course of myocardial infarction S. A. Okrugin, A. N. Repin
13 [GO] 2025―Mar―12 Celen-Gellerstedt syndrome with the development of microhemorrhages in the lungs after reinfection with SARS-CoV-2 L. P. Romanova, O. V. Alpidovskaya, O. I. Moskovskaya, S. V. Lezhenina, A. V. Moskovsky
14 [GO] 2025―Mar―12 Respiratory outcomes and predictors of respiratory failure development during surgical myocardial revascularisation in patients who underwent COVID-19 V. S. Ermakov, V. N. Kravchuk, O. Ya. Porembskaya
15 [GO] 2025―Feb―07 Nodular goiter and anamnesis of COVID-19: clinical and pathogenetic relationships, sonographic and cytological features A. I. Nekrasov, I. G. Pochinka, L. G. Strongin, N. Yu. Orlinskaya, L. A. Lugovaya, O. V. Melnichenko
16 [GO] 2025―Feb―07 A case of COVID-19 infection, complicated by viral covid pneumonia, spontaneous rupture in the thinned part of a chronic aneurysm, with type 2 myocardial infarction O. V. Alpidovskaya, N. E. Himaldinova, L. P. Romanova
17 [GO] 2025―Feb―07 Pathogenesis of nervous system lesions and clinical syndromes of the new coronavirus infection COVID-19 M. B. Patsenko, V. L. Glotko, E. A. Shirokov, I. N. Gaivoronskii
18 [GO] 2024―Nov―21 Procalcitonin in new coronavirus infection (COVID-19), complicated by pneumonia, sepsis, in patients with diabetes mellitus E. A. Titova, T. A. Lysenko, A. G. Koblov
19 [GO] 2024―Nov―21 Autonomic dysfunction syndrome in patients with consequences of a new coronavirus infection in outpatient practice E. A. Antipenko, A. V. Shulyndin, A. S. Muromtsev
20 [GO] 2024―Jul―26 Diagnosis and treatment of acute appendicitis in patients with the new coronavirus infection COVID-19 A. A. Kaverina, S. A. Vavrinchuk, P. M. Kosenko
21 [GO] 2024―Jul―26 A decrease in the concentration of free blood glutathione in the acute phase of coronavirus infection L. A. Kolevatova, Yu. V. Ovchinnikov, N. I. Gulyaev, A. A. Prokhorchik, L. L. Euro
22 [GO] 2024―Jun―02 COVID-19 and diabetes: health risks E. S. Sokolova, M. A. Palamarenko, A. A. Osipov, A. M. Chaulin, E. V. Eliseeva, E. S. Koryakin
23 [GO] 2024―May―09 Dynamics of clinical and echocardiographic parameters of patients with cardiovascular diseases 3, 12 and 26 months after COVID-19 pneumonia E. I. Yaroslavskaya, V. D. Garanina, N. E. Shirokov, D. V. Krinochkin, N. A. Osokina, I. O. Korovina, et al. (+3)
24 [GO] 2024―Apr―15 AL-amyloidosis after coronavirus infection with acute atypical heart injury Yu A. Lutokhina, O. V. Blagova, D.  Kh. Ainetdinova, N.  D. Sarkisova, E. A. Kogan, V. V. Rameev
25 [GO] 2024―Feb―23 Novel coronavirus infection (COVID-19) - clinical recommendations A. A. Zaitsev
26 [GO] 2024―Feb―23 On the impact of the COVID-19 pandemic on the incidence of community-acquired pneumonia on the example of the region of the European North of Russia T. A. Karapetyan, N. V. Dorshakova, I. V. Peshkova
27 [GO] 2024―Feb―23 Factors of poor prognosis for new coronavirus infection in patients with cardiovacular pathology L. Yu. Eliseeva, N. Yu. Borovkova, P. S. Zubeev, G. N. Zubeeva, E. S. Yumanova
28 [GO] 2024―Feb―23 A case of death in a patient with Marfan syndrome after re-infection with SARS-CoV-2 O. V. Alpidovskaya
29 [GO] 2024―Feb―23 Treatment of heart rhythm disturbances associated with SARS-CoV-2 infection with anti-inflammatory drugs Z. N. Sukmarova, E. G. Zotkin
30 [GO] 2023―Nov―14 Comparative characteristics of the clinical course of a new coronavirus infection depending on the vaccination status S. A. Sokotun, A. I. Simakova, N. G. Plekhova, A. O. Mikhailov, M. D. Barbashev, D. Yu. Barbasheva, et al. (+2)
31 [GO] 2023―Jun―01 Clinical case of methotrexate overdose, the peculiarity of diagnostics in the conditions of the COVID-19 pandemic I. V. Zaborskikh, V. B. Simonenko, S. Kh. Sarmanaev, R. R. Tuktarova, Yu. O. Yurina
32 [GO] 2023―Apr―13 Prevalence of cardiovascular pathology and relationship of left ventricular global longitudinal strain three months after COVID-19 D. V. Krinochkin, E. I. Yaroslavskaya, N. E. Shirokov, E. A. Gorbatenko, E. P. Gultyaeva, I. R. Krinochkina, et al. (+4)
33 [GO] 2023―Apr―13 Analysis of the course and outcomes of COVID-19 in HIV infected patients according to the infectious diseases’ hospital of Moscow M. V. Nagibina, N. A. Smirnov, T. P. Bessarab, N. N. Martynova, A. I. Mazus, S. V. Krasnova, et al. (+2)
34 [GO] 2023―Apr―13 Organization of a system for providing medical care to patients with a new coronavirus infection in Central Clinical Hospital named after P.V. Mandrykа A. V. Demyanenko, N. A. Varavin
35 [GO] 2023―Mar―27 Arterial hypertension in COVID-19 А. S. Zmitrukevich, A. E. Mamedova
36 [GO] 2023―Jan―19 The dynamic and structure of mortality from respiratory diseases and COVID-19 in the Russian Federation for 2019-2021 I. V. Samorodskaya, E. V. Bolotova, A. V. Dudnikova
37 [GO] 2022―Oct―31 Сauses, risk factors, diagnostics and treatment of gastrointestinal bleeding in patients with a novel coronavirus infection (COVID-19) A. A. Sheptulin, S. S. Kardasheva, A. A. Kurbatova
38 [GO] 2022―Sep―16 Enhancement the eff ec- tiveness of therapy of the new COVID-19 coronavirus infection using interferon alpha-2b in adults A. V. Mordyk, E. N. Vyzhlova, K. Yu. Samsonov, L. A. Zenkova, A. O. Ptukhin, V. V. Kukhlov, et al. (+3)
39 [GO] 2022―Sep―16 The COVID-19 pandemic as a consequence of sustainable changes in the planet’s biosphere G. P. Stupakov, N. V. Shcherbinina, E. A. Shirokov
40 [GO] 2022―Jul―22 Phenomenon of reduced blood oxygen saturation in COVID-19 patients after the use of monoclonal antibodies K. V. Zhdanov, K. V. Kozlov, P. I. Miklush, N. I. Lvov, O. V. Maltsev, V. V. Sharabkhanov, et al. (+7)
41 [GO] 2022―Jun―25 The wickedness of coronavirus and its treatment. The intuition or standard? A. N. Chepurnaya, T. Yu. Lekhmus
42 [GO] 2022―Apr―22 Laboratory-instrumental and histological data characteristic of myocardial changes in COVID-19 A. V. Tsokolov, I. B. Iliin, R. H. Umaev, A. V. Vertelkin
43 [GO] 2022―Apr―22 Neuropsychiatric and behavioral disorders in patients with COVID-19 V. V. Rassokhin, N. A. Belyakov, A. A. Yakovlev, O. E. Simakina
44 [GO] 2022―Mar―05 The risk of cardiac and cerebrovascular complications in patients with concomitant cardiovascular diseases who have had COVID-19 E. S. Klyachina, O. G. Smolenskaya
45 [GO] 2022―Mar―05 COVID-19: аnalysis of medical death certificate I. V. Samorodskaya, T. K. Chernyavskaya, E. P. Kakorina
46 [GO] 2022―Jan―27 Spontaneous hematomas in COVID-19: causes, clinic, diagnosis and treatment M. V. Nagibinа, A. S. Sycheva, I. A. Koshelev, M. A. Malyavina, A. A. Solodov, A. L. Kebinа, et al. (+4)
47 [GO] 2021―Dec―02 Type IV myocardial infarction associated with acute stent thrombosis in the early period after revascularization in a patient with new coronavirus infection COVID-19 V. N. Ardashev, A. V. Nagovitsyn, N. V. Zakaryan, O. P. Donetskaya, G. E. Kubenskiy, E. B. Molokhoev, et al. (+4)
48 [GO] 2021―Dec―02 Interrelation of global changes in the planet's biosphere with the expansion of viruses and the COVID-19 pandemic E. A. Shirokov
49 [GO] 2021―Sep―20 Pseudomembranous colitis after COVID-19 antibacterial therapy M. A. Skuratova, P. A. Lebedev, Т. V. Larina, A. P. Sokolov, E. A. Voishcheva, P. A. Dulin
50 [GO] 2021―Sep―16 Possi bilities and perspectives of colchicine application in complex therapy in patients with COVID-19 P. A. Lebedev, A. A. Garanin, E. V. Paranina, A. V. Chernyshev, P. A. Dulin
51 [GO] 2021―Sep―16 Pericardial eff usion as a new specifi c symptom of SARS-CoV-2 Z. N. Sukmarova, V. B. Simonenko, F. M. Ibragimova, A. V. Demyanenko
52 [GO] 2021―Jul―03 Features of the psychoemotional state of doctors providing medical care in the context of the COVID-19 pandemic A. A. Litvinova, A. V. Kravtsiva, A. V. Asmolovsky, S. V. Shamatkova
53 [GO] 2021―Jun―05 Compromised liver function in patients with a new coronavirus infection COVID-19 L. Yu. Eliseeva, A. S. Eliseev, N. Yu. Borovkova, A. S. Vasilkova
54 [GO] 2021―Feb―08 The first experience of treatment applied to patients with pulmonary embolism that developed on the COVID-19 background S. A. Fedorov, A. P. Medvedev, A. L. Maksimov, N. Yu. Borovkova, M. B. Sukhanova, V. V. Pichugin, et al. (+3)
55 [GO] 2021―Feb―08 Effect of thymalin on adaptive immunity in complex therapy for patients with COVID-19 V. Kh. Khavinson, B. I. Kuznik, V. A. Volchkov, S. A. Rukavishnikova, O. N. Titova, T. A. Akhmedov, et al. (+4)
56 [GO] 2021―Jan―11 Pathogenetic basis of venous thromboembolic complications as deuteropathies of COVID-19 S. A. Fedorov, A. P. Medvedev, N. Yu. Borovkova, E. V. Taranov
57 [GO] 2020―Nov―26 Experience with the use of glucocorticoids and netakimab in the treatment of patients with COVID-19 in outpatient settings R. Е. Pavlov, S. V. Tsarenko, A. V. Sekinaeva, P. N. Rybin, M. V. Nagibinа, E. V. Soshnikovа, M. S. Klimova
58 [GO] 2020―Nov―26 Hemocoagulation in coronavirus viral disease: analyses of the problem and our opinion I. N. Bokarev, L. V. Popova
59 [GO] 2020―Oct―30 Vasculopathy in patients with severe COVID-19 infection Т. V. Beketova, E. V. Nasonov
60 [GO] 2020―Sep―18 Complications in COVID-19 patients. Suggested mechanisms of correction V. Kh. Khavinson, B. I. Kuznik
 [1] 

60 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec